Saturday, October 31, 2026

SVB Financial Group Stock Bullish Momentum With A 9% Jump At Session Start Today

ViaNews Editorial Team

February 2, 2023

SVB Financial Group Stock Bullish Momentum With A 9% Jump At Session Start Today

(VIANEWS) - Shares of SVB Financial Group (NASDAQ: SIVB) jumped 9.71% to $343.82 at 10:46 EST on Thursday, after two successive sessions in a row of gains. NASDAQ is rising 1.95% to $12,046.50, after two consecutive sessions in a row of gains. This seems, up to now, an all-around positive trend exchanging session today.

SVB Financial Group's last close was $313.38, 52.41% under its 52-week high of $658.47.

About SVB Financial Group

SVB Financial Group, a diversified financial services company, offers various banking and financial products and services. It operates through four segments: Global Commercial Bank, SVB Private Bank, SVB Capital, and SVB Securities. The Global Commercial Bank segment provides commercial banking products and services, including credit, treasury management, foreign exchange, trade finance, and other financial products and services. This segment also offers traditional term and equipment loans, asset-based loans, revolving lines of credit, warehouse facilities, recurring revenue and acquisition finance facilities, mezzanine lending, corporate working capital facilities, and credit card programs; treasury management products and services; business and analysis checking, money market, multi-currency, in-country bank, and sweep accounts; receivables services, which include merchant services, remote capture, lockbox, and fraud control services; wire transfer and automated clearing house payment services; business bill pay, credit and debit cards, account analysis, and disbursement services. In addition, it offers foreign exchange and trade finance products and services; letters of credit; and investment services and solutions. The SVB Private Bank segment offers mortgages, home equity lines of credit, restricted and private stock loans, capital call lines of credit, and other secured and unsecured lending products; planning-based financial strategies, wealth management, family office, financial planning, tax planning, and trust services; and real estate secured loans. The SVB Capital segment provides venture capital investment services. The SVB Securities segment provides investment banking services; products and services, including capital raising, merger and acquisition advisory, equity research, and sales and trading. It operates through 56 offices in the United States and internationally. The company was founded in 1983 and is headquartered in Santa Clara, California.

Earnings Per Share

As for profitability, SVB Financial Group has a trailing twelve months EPS of $30.38.

PE Ratio

SVB Financial Group has a trailing twelve months price to earnings ratio of 11.32. Meaning, the purchaser of the share is investing $11.32 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.23%.

Volume

Today's last reported volume for SVB Financial Group is 864223 which is 17.56% below its average volume of 1048380.

Moving Average

SVB Financial Group's worth is way higher than its 50-day moving average of $236.27 and below its 200-day moving average of $358.52.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.2%, now sitting on 5.83B for the twelve trailing months.

Yearly Top and Bottom Value

SVB Financial Group's stock is valued at $343.82 at 10:46 EST, way under its 52-week high of $658.47 and way higher than its 52-week low of $198.10.

More news about SVB Financial Group (SIVB).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com